National Comprehensive Cancer Network
500 Old York Road, Suite 250
71 articles with National Comprehensive Cancer Network
NCCN Advances Cancer Research and Oncology Career Development with Young Investigator Awards, Poster Presentations, and Fellows Program
The National Comprehensive Cancer Network supports cancer research and treatment through various programs during and after the NCCN 2019 Annual Conference.
Agency Clarifies CDC Guideline Not Meant to Limit Access to Appropriate Pain Management for Individuals with Cancer, Sickle Cell Disease
NCCN 2019 Annual Conference Addresses How to Improve Cancer Care Worldwide Amid Intersecting Public Health Crises
Oncology professionals from all over the world met in Orlando to discuss how to better address the needs of people with cancer. Join the conversation online with the hashtag #NCCNac19
National Comprehensive Cancer Network Recognizes Five Individuals for Outstanding Achievements in Improving Cancer Care
National Comprehensive Cancer Network® (NCCN®) today announced the recipients of a series of awards honoring individuals whose significant contributions fueled progress in improving and facilitating quality, effective, efficient, and accessible cancer care over the past year.
Dr. Walters elected chair of the Board of the alliance of leading cancer centers; UW Carbone's Ruth O'Regan elected Vice-Chair
NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology
The quality improvement studies will focus on methods of intervention that can be implemented across a variety of different oncology practice settings.
BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) and ERBITUX® (cetuximab) or panitumumab Recommended by the NCCN Guidelines as a Treatment Option for Patients with Advanced BRAF-mutant Colorectal
Array BioPharma Inc. announced that the National Comprehensive Cancer Network® has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to include BRAFTOVI® in combination with MEKTOVI® and an anti-EGFR antibody as a Category 2a treatment for patients with BRAFV600E-mutant metastatic colorectal cancer, after failure of one or two prior lines of therapy for metastatic disease.
The studies will be funded through a collaboration between the NCCN Oncology Research Program and Taiho Oncology, Inc. to investigate the effectiveness of trifluridine and tipiracil
New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year.
Integrating Heart Disease and Cancer Care Could Reduce Overall Health Care Costs, According to Researchers
Study in JNCCN finds coronary artery disease costs increase dramatically in patients who are diagnosed with cancer
National Comprehensive Cancer Network Updates Resources for Improving Cancer Care in the Middle East & North Africa
NCCN Adaptations updated to streamline care and encourage best practices for cancer treatment in the MENA region
NCCN Guidelines Raise Standards for Cancer Care Worldwide by Exceeding 10 Million Downloads in 2018 -- Up 26% Over 2017
The NCCN Guidelines are the most frequently-updated guidelines in any medical discipline, and are proven to improve outcomes, equity, and quality-of-life for people with cancer.
NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment
Project to focus on preclinical and clinical research with cyclin dependent kinase (CDK)4 & 6 inhibitors
National Comprehensive Cancer Network Announces Abramson Cancer Center of the University of Pennsylvania as New Member Institution
The Abramson Cancer Center joins 27 other leading academic cancer centers from across the United States in creating the most frequently updated cancer care guidelines worldwide.
'NCCN Guidelines for Patients®: Oral Cancers' provides information about oral cancers for patients and caregivers.
New agreement between National Comprehensive Cancer Network and Syapse will augment health information technology around cancer care
NCCN Awarded $2 Million in Research Funding from Taiho Oncology to Study Trifluridine and Tipiracil in Various Cancers
The National Comprehensive Cancer Network's Oncology Research Program received a grant to investigate effectiveness of trifluridine and tipiracil for treatment of people with colorectal, gastric, and other cancers
Updated Breast Cancer Resources and Events from NCCN Keep Patients and Doctors Worldwide Informed during Breast Cancer Awareness Month
Latest metastatic breast cancer treatment options to be explained in webinar for patients and loved ones, corresponding with updated patient guidelines, on October 22 and 29
New NCCN Guidelines for Patients: NET provides background and treatment information for the type of cancer experienced by Aretha Franklin and Steve Jobs
National Blood Cancer Experts Provide Updates on CAR T-Cell Therapy, Leukemia, Lymphoma, and Myeloma; New NCCN Guidelines for Systemic Mastocytosis Now Available
The NCCN 13th Annual Congress: Hematologic Malignancies™ examines novel treatments, major milestones, and challenging case studies for hematologic oncology. Join the conversation online with the hashtag #NCCNhem18.